Skip to main content
2025 National Biotechnology Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Mu Chen, PhD (he/him/his)

Principal Scientist
Regeneron Pharmaceuticals
New Providence, New Jersey

Mu Chen earned his PhD in 2014 from Rutgers University under Professor Jeehiun K. Lee and has since worked in the regulated bioanalysis field within the pharmaceutical industry. He is currently a Principal Scientist in the Bioanalytical Strategy Group at Regeneron, serving as the Bioanalytical Science Lead for the clinical development of monoclonal antibodies (mAbs) and new modalities. His work also includes immunogenicity assessment of drug candidates in clinical trials and bioanalytical strategy planning. Before joining Regeneron, Mu worked at Celgene/Bristol Myers Squibb and Frontage Laboratories, Inc., serving as a bioanalytical lead and group leader supporting both non-clinical and clinical drug development. His work has focused on method development, validation, and application of LC-MS and ligand-binding assays for the quantitation of both small and large molecule drugs and biomarkers.

Disclosure information not submitted.

Presentation(s):